A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

NCT01283334 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Neoplasms
Cancer of the Head and Neck

Interventions

DRUG: Carboplatin
DRUG: Cetuximab
DRUG: RAD001

Sponsor

Emory University

Collaborators

[object Object]